Automation index

How much of a Car salesperson’s job can AI already do?

A valuer and stock come earlier. Closing the deal without the car coming back do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

22%

AI can already do 22% of this job.

#413 / 653

Car salesperson

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Stock, valuation and the card. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Test drive, objections and the one who will not decide. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Finance, the bank and the one who fails. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Handover, the extra and the one who argues the scratch. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
The boss, the margin and not giving the discount away. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Close the deal, and it not coming back. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		22%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 653

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low